Deyang People's Hospital Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2016
NCT02728180
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Deyang People's Hospital | People’s Hospital of Deyang City

Active Ingredients

Drugs in Phase 4 Trials (1)

xingnaojing (1 trial)

Drugs in Phase 3 Trials (1)

borneol (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 3)

Cerebral Infarction (Phase 4)

Colorectal Neoplasms (Phase 3)

Ischemia (Phase 4)

Peritoneal Neoplasms (Phase 3)

Stroke (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2